Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia
2013
Background/Aims: The aim of this paper is to report the treatment of type 2 nonproliferative idiopathic macular telangiectasia (IMT) with intravitreal bevacizumab
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
6
Citations
NaN
KQI